IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Provectus Biopharmaceuticals

CUSIP: 74373P116 | 8 institutional holders

Quarters

Q3 2016Q2 2016Q1 2016Q4 2015Q3 2015
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2016

Cormorant Asset Management, LP2,200,000
0.0% of portfolio›$114
Millennium Management LLC500,000
0.0% of portfolio›$26
Creative Planning149,570
0.0% of portfolio›$8
UBS Group AG9,926
0.0% of portfolio›$1
StyleTurnoverLocationFiled
Cormorant Asset Management, LP
2,200,000$1140.0%CoreMediumBoston, MA2016-11-14
Millennium Management LLC
500,000$260.0%CoreVery HighNew York, NY2016-11-14
Creative Planning
149,570$80.0%IndexVery LowOverland Park, KS2016-10-12
UBS Group AG
9,926$10.0%CoreMediumZurich, Switzerland2016-11-14